Marco Pugliese
Managing Director
EIT Health Spain

Bachelor in Veterinary Science in 1994 (University of Perugia, Italy). PhD in Neuroscience in 2005 (University of Barcelona (UB)) with research based on the characterization of cognitive dysfunction in companion dogs and its usefulness as an alternative model of Alzheimer’s disease. Research prize of the Royal Spanish Academy of Veterinary Science (2005) with a study based on the selective neurodegeneration in dogs’ CNS. Co-founder and CEO of Neurotec Pharma (2006-2014) a spin-off company of the UB created to develop a new drug to treat neuroinflammation and neurodegeneration. Manager of Innovation and Technology Transfer at the Research Institute of Vall d’Hebron (VHIR) (2015). He is currently Director of the Spanish node of EIT Health. Dr Pugliese is co-inventor of 7 patents related to the development of treatment for CNS diseases and he is author of 24 international publications in the field of Neuroscience.